Search Results - "VOIGT, Heike"

Refine Results
  1. 1
  2. 2

    Mouse models for melanoma: a personal perspective by Becker, Jürgen C., Houben, Roland, Schrama, David, Voigt, Heike, Ugurel, Selma, Reisfeld, Ralph A.

    Published in Experimental dermatology (01-02-2010)
    “…Please cite this paper as: Mouse models for melanoma: a personal perspective. Experimental Dermatology 2010; 19: 157–164. :  Complex biological processes often…”
    Get full text
    Journal Article
  3. 3

    Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression by Wobser, Marion, Voigt, Heike, Houben, Roland, Eggert, Andreas O, Freiwald, Matthias, Kaemmerer, Ulrike, Kaempgen, Eckhart, Schrama, David, Becker, Juergen C

    Published in Cancer Immunology, Immunotherapy (01-07-2007)
    “…Recent reports have demonstrated that the enzyme indoleamine 2,3-dioxygenase (IDO) is upregulated in human dendritic cells (DCs) upon in vitro maturation. IDO…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Myosin IB from Entamoeba histolytica is involved in phagocytosis of human erythrocytes by Voigt, H, Olivo, J C, Sansonetti, P, Guillén, N

    Published in Journal of cell science (15-04-1999)
    “…Entamoeba histolytica is a protozoan parasite that causes amoebic dysentery in humans. The disease is prevalent worldwide. Infection with E. histolytica…”
    Get full text
    Journal Article
  6. 6

    Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes by Hofmann, Uta B, Voigt, Heike, Andersen, Mads H, Straten, Per thor, Becker, Jürgen C, Eggert, Andreas O

    Published in European journal of immunology (01-05-2009)
    “…Survivin is overexpressed in several malignancies and in tumor-associated endothelium making it an attractive target for therapeutic cytotoxic T-cell…”
    Get full text
    Journal Article
  7. 7

    Placement makes a difference: Accuracy of an accelerometer in measuring step number and stair climbing by Lützner, Cornelia, Voigt, Heike, Roeder, Ingo, Kirschner, Stephan, Lützner, Jörg

    Published in Gait & posture (01-04-2014)
    “…Highlights • Stair climbing is not recorded accurately by any placement of the accelerometer. • Placement of the accelerometer makes a difference during slow…”
    Get full text
    Journal Article
  8. 8

    MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib by Houben, Roland, Voigt, Heike, Noelke, Christiane, Hofmeister, Valeska, Becker, Juergen C, Schrama, David

    Published in Molecular cancer therapeutics (01-02-2009)
    “…Sorafenib, originally developed as CRAF inhibitor but soon recognized as a multikinase inhibitor, is currently widely tested for the treatment of different…”
    Get full text
    Journal Article
  9. 9

    CD147 Impacts Angiogenesis and Metastasis Formation by Voigt, Heike, Vetter-Kauczok, Claudia S., Schrama, David, Hofmann, Uta B., Becker, Jürgen C., Houben, Roland

    Published in Cancer investigation (01-01-2009)
    “…CD147 is highly expressed on many tumor cells; its role for tumor invasiveness and metastasis has been deduced from its capacity to induce MMPs, i.e., MMP-1,…”
    Get full text
    Journal Article
  10. 10

    Leishmania major-Specific B Cells Are Necessary for Th2 Cell Development and Susceptibility to L. major LV39 in BALB/c Mice by Ronet, Catherine, Voigt, Heike, Himmelrich, Hayo, Doucey, Marie-Agnes, Hauyon-La Torre, Yazmin, Revaz-Breton, Melanie, Tacchini-Cottier, Fabienne, Bron, Claude, Louis, Jacques, Launois, Pascal

    Published in The Journal of immunology (1950) (01-04-2008)
    “…B lymphocytes are considered to play a minimal role in host defense against Leishmania major. In this study, the contribution of B cells to susceptibility to…”
    Get full text
    Journal Article
  11. 11

    Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue by Schrama, David, Voigt, Heike, Eggert, Andreas O., Xiang, Rong, Zhou, He, Schumacher, Ton N. M., Andersen, Mads H., thor Straten, Per, Reisfeld, Ralph A., Becker, Jürgen C.

    Published in Cancer Immunology, Immunotherapy (01-01-2008)
    “…Background We previously demonstrated that targeting lymphotoxin α (LTα) to the tumor evokes its immunological destruction in a syngeneic B16 melanoma model…”
    Get full text
    Journal Article
  12. 12

    Overexpression of myosin IB in living Entamoeba histolytica enhances cytoplasm viscosity and reduces phagocytosis by Marion, Sabrina, Wilhelm, Claire, Voigt, Heike, Bacri, Jean-Claude, Guillén, Nancy

    Published in Journal of cell science (01-07-2004)
    “…The human parasite Entamoeba histolytica is an ancient protozoan that expresses only one unconventional myosin, which has homology with myosin IB from other…”
    Get full text
    Journal Article
  13. 13

    Identification and characterization of survivin‐derived H‐2K b ‐restricted CTL epitopes by Hofmann, Uta B., Voigt, Heike, Andersen, Mads H., Straten, Per thor, Becker, Jürgen C., Eggert, Andreas O.

    Published in European journal of immunology (01-05-2009)
    “…Abstract Survivin is overexpressed in several malignancies and in tumor‐associated endothelium making it an attractive target for therapeutic cytotoxic T‐cell…”
    Get full text
    Journal Article
  14. 14

    immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines by Sørensen, Rikke Bæk, Junker, Niels, Kirkin, Alexei, Voigt, Heike, Svane, Inge Marie, Becker, Jürgen C, thor Straten, Per, Andersen, Mads Hald

    Published in Cancer Immunology, Immunotherapy (01-05-2009)
    “…Among the relatively large number of known tumor-associated antigens (TAA) which are recognized by human CD8 T-cells, Melan-A/MART-1 is one of the most--if not…”
    Get full text
    Journal Article
  15. 15
  16. 16

    New insights into the role of the cytoskeleton in phagocytosis of Entamoeba histolytica by Voigt, Heike, Guillén, Nancy

    Published in Cellular microbiology (01-11-1999)
    “…Entamoeba histolytica, a human parasite, crosses the natural barriers of the intestine and, in turn, spreads into the deeper organs, resulting in amoebiasis…”
    Get full text
    Journal Article
  17. 17

    Therapeutic efficacy of tumor-targeted IL2 in LTalpha(-/-) mice depends on conditioned T cells by Schrama, David, Voigt, Heike, Eggert, Andreas O, Xiang, Rong, Reisfeld, Ralph A, Becker, Jürgen C

    Published in Cancer immunology, immunotherapy : CII (01-07-2006)
    “…An effective immunological eradication of tumors by the adaptive immune system depends on T cell priming, expansion of specific T cells and their effector…”
    Get full text
    Journal Article
  18. 18

    Therapeutic efficacy of tumor-targeted IL2 in LT[alpha]-/- mice depends on conditioned T cells by Schrama, David, Voigt, Heike, Eggert, Andreas O, Xiang, Rong, Reisfeld, Ralph A, Becker, Jürgen C

    Published in Cancer immunology, immunotherapy (01-07-2006)
    “…An effective immunological eradication of tumors by the adaptive immune system depends on T cell priming, expansion of specific T cells and their effector…”
    Get full text
    Journal Article
  19. 19

    Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue by Schrama, David, Voigt, Heike, Eggert, Andreas O, Xiang, Rong, Zhou, He, Schumacher, Ton N M, Andersen, Mads H, thor Straten, Per, Reisfeld, Ralph A, Becker, Jürgen C

    Published in Cancer immunology, immunotherapy : CII (01-01-2008)
    “…We previously demonstrated that targeting lymphotoxin alpha (LTalpha) to the tumor evokes its immunological destruction in a syngeneic B16 melanoma model…”
    Get full text
    Journal Article
  20. 20

    Immunological tumor destruction in a murine melanoma model by targeted LT[alpha] independent of secondary lymphoid tissue by Schrama, David, Voigt, Heike, Eggert, Andreas O, Xiang, Rong, Zhou, He, Schumacher, Ton N; M, Andersen, Mads H, Thor Straten, Per, Reisfeld, Ralph A, Becker, Jürgen C

    Published in Cancer immunology, immunotherapy (01-01-2008)
    “…We previously demonstrated that targeting lymphotoxin α (LTα) to the tumor evokes its immunological destruction in a syngeneic B16 melanoma model. Since…”
    Get full text
    Journal Article